Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital

Author: Saltoglu N.   Dalkiran A.   Tetiker T.   Bayram H.   Tasova Y.   Dalay C.   Sert M.  

Publisher: Blackwell Publishing

ISSN: 1198-743X

Source: Clinical Microbiology & Infection, Vol.16, Iss.8, 2010-08, pp. : 1252-1257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content